May 2023
Philadelphia, PA., May 4, 2023– NeuExcell Therapeutics (www.neuexcell.com), a gene therapy company focusing on neurodegenerative diseases, has announced a $15+ million Series Pre-A+ financing round.
Oct 2022
Sep 2022
NeuExcell Therapeutics has been invited to participate in the upcoming UBS Biotechnology Private Company Symposium, Wednesday September 21, 2022
May 2022
Walter E. Washington Convention Center 801 Mt Vernon Pl NW Washington, D.C.
May 2022
2022 PACT Enterprise Awards for Life Sciences and Health Care Startup - NeuExcell Therapeutics Nomination Video